IL-5 enhances human mast cell survival and interferon responses to viral infection
Journal of Allergy and Clinical Immunology · 2025-06 · 155 (6) · 1968-1980
DOI: 10.1016/j.jaci.2025.02.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025-06. Verfasst von Jasmine Barra und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada; Beatrice Hunter Cancer Research Institute, Halifax, No…. Hauptthemen laut MEDLINE: Mast Cells, Interferons, Interleukin-5, Virus Diseases. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beatrice Hunter Cancer Research Institute, Canadian Institutes of Health Research, Dalhousie Medical Research Foundation.
Abstract (Originalsprache)
BACKGROUND: Mast cells are important sentinel cells in defense against mucosal infection. Exacerbations of allergic asthma and asthma deaths have been associated with respiratory viral infections. Elevated levels of IL-5 have been associated with the pathogenesis of severe atopic diseases, many of which respond to IL-5 blockade. OBJECTIVE: We sought to examine the impact of IL-5 signaling on mast cells infected with respiratory viruses. METHODS: Cord blood-derived human mast cells were treated with IL-5 or left untreated and infected with human coronavirus OC43, respiratory syncytial virus (RSV), or oncolytic reovirus. Mast cell expression of interferons and of interferon-stimulated genes was evaluated. Total RNA sequencing was performed to determine the impact of IL-5 on the transcriptome of human mast cells, and related functional assays were performed. RESULTS: IL-5-treated mast cells produced significantly more type I and III interferons than did controls not treated with IL-5. Mechanistically, IL-5 treatment led to greater expression of the prosurvival factor B-cell lymphoma 2 (BCL2) and endothelial PAS domain protein 1 (EPAS1) and protected mast cells from apoptosis-induced stress. IL-5 blockade was associated with a decrease in EPAS1 expression in the peripheral blood of asthmatic patients, as shown by transcriptomic data from clinical trials of mepolizumab and benralizumab. CONCLUSIONS: IL-5 signaling selectively promotes interferon responses in mast cells and maintains mast cell populations during mucosal viral infection via a novel IL-5/EPAS1 axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada; Beatrice Hunter Cancer Research Institute, Halifax, Nova Scotia, Canada.
- Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada.
- Beatrice Hunter Cancer Research Institute, Halifax, Nova Scotia, Canada; Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada; Division of Hematopathology, Department of Pathology and Laboratory M…
- Beatrice Hunter Cancer Research Institute, Halifax, Nova Scotia, Canada; Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada.
- Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada; Beatrice Hunter Cancer Research Institute, Halifax, Nova Scotia, Canada. Electronic address: Ian.Haidl@dal.ca.
- Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada; Beatrice Hunter Cancer Research Institute, Halifax, Nova Scotia, Canada. Electronic address: Jean.Marshall@dal.ca.
Förderung
- Beatrice Hunter Cancer Research Institute
- Canadian Institutes of Health Research
- Dalhousie Medical Research Foundation
Zitieren
APA
Barra, J., Liwski, C. R., Phonchareon, P., Portales-Cervantes, L., Gaston, D., Karakach, T. K., Haidl, I. D., & Marshall, J. S. (2025). IL-5 enhances human mast cell survival and interferon responses to viral infection. Journal of Allergy and Clinical Immunology, 155(6), 1968-1980. https://doi.org/10.1016/j.jaci.2025.02.025
Vancouver
Barra J, Liwski CR, Phonchareon P, Portales-Cervantes L, Gaston D, Karakach TK, et al. IL-5 enhances human mast cell survival and interferon responses to viral infection. Journal of Allergy and Clinical Immunology. 2025;155(6):1968-1980. doi:10.1016/j.jaci.2025.02.025
BibTeX
@article{Barra2025,
author = {Barra, Jasmine and Liwski, Christopher R and Phonchareon, Phoebe and Portales-Cervantes, Liliana and Gaston, Daniel and Karakach, Tobias K and Haidl, Ian D and Marshall, Jean S},
title = {IL-5 enhances human mast cell survival and interferon responses to viral infection},
journal = {Journal of Allergy and Clinical Immunology},
year = {2025},
volume = {155},
number = {6},
pages = {1968--1980},
doi = {10.1016/j.jaci.2025.02.025}
}
EUVIMED